Funding No funding was received to assist with the preparation of this manuscript
[6] [10] The correct tier is therefore investigational, development halted for lack of demonstrated efficacy not approved, and emphatically not a compound that succeeded in trials
Journal of Clinical Investigation, 127( 12), 42174227
Swiss Chems is no longer selling semaglutide or retatrutide, though it still sells peptides for research purposes
Understanding what peptides are used for in the context of appetite and metabolism helps frame semaglutide within the broader category of signaling molecules that influence fundamental body processes
Food and Drug Administration announced on April 30, 2026, that it is considering removing several popular GLP-1 medications from the agencys 503B bulks list a decision that could significantly reduce the supply of compounded versions of these drugs in the United States